News Life and Health30 May 2019

Japan:Public health insurance to cover genome testing for cancer patients


Japan's public health insurance system is set to cover genomic testing for cancer patients who have not responded to conventional cancer treatments from 1 June onwards, reported The Japan Times citing a recent decision made by the health ministry. Under the new inclusion, patients will only have to pay 10-30% of testing fees.

Archived articles are available to Magazine subscribers only.

If you are already a subscriber

OR sign-up for a trial access here

For Full Access to the magazine SUBSCRIBE here.

Note that your comment may be edited or removed in the future, and that your comment may appear alongside the original article on websites other than this one.

 
Error : Object reference not set to an instance of an object.

Recent Comments

Other News

Follow Asia Insurance Review